Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/7/2025

Causes of High Antiphospholipid Antibodies (aPL)

Introduction to aPL

  • Antiphospholipid antibodies arise primarily in autoimmune conditions, especially systemic lupus erythematosus, but also occur in infections, malignancies, drug exposures, and in otherwise healthy individuals without any identifiable underlying disease 1, 2

Primary Autoimmune Conditions

  • Systemic Lupus Erythematosus (SLE) is the most common autoimmune disease associated with aPL, with approximately 37% of SLE patients testing positive for these antibodies 2

Infections

  • Transient aPL positivity commonly occurs during acute infections, which is why confirmation testing at least 12 weeks apart is required for APS diagnosis 3, 4

Drug-Induced aPL

  • Certain medications can induce transient aPL production, requiring repeat testing after drug discontinuation to confirm persistence 4
  • Drug-induced aPL typically resolve after medication cessation 4
  • Approximately 6% of pregnant women without diagnosed APS test positive for aPL and are at risk for pregnancy complications including recurrent fetal loss, preeclampsia, intrauterine growth restriction, and fetal distress 1
  • aPL levels may fluctuate during pregnancy, with 25% of LA-positive patients becoming negative in the second or third trimester 4

Laboratory Considerations

  • High-risk aPL profile includes lupus anticoagulant, double-positive, triple-positive, or persistently high titers, which is significant for risk stratification 5, 6
  • Low-risk aPL profile consists of isolated anticardiolipin or anti-β2-glycoprotein I antibodies at low-to-medium titers, particularly if transiently positive 5, 6
  • IgG isotype is generally more clinically significant than IgM, though IgM can be important in obstetric APS 3

Common Pitfalls

  • Do not diagnose APS based on single positive test - persistence must be confirmed with repeat testing at least 12 weeks apart 3, 4
  • Timing of testing matters - aPL levels may decrease during acute thrombosis due to antibody deposition at the thrombotic site, and may fluctuate during pregnancy 4
  • Anticoagulation interferes with LA testing - consider testing for antiphosphatidylserine/prothrombin antibodies as a surrogate when LA testing is unreliable 7
  • Low positive results near cutoff values should be interpreted cautiously given assay imprecision of up to 10% 4